Guardian Pharmacy Services (NYSE:GRDN) Stock Rating Upgraded by Wall Street Zen

Guardian Pharmacy Services (NYSE:GRDN – Get Free Report) was upgraded by analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Saturday, Wall Street Zen reports.

A number of other equities research analysts have also weighed in on GRDN. Truist Financial lifted their price objective on Guardian Pharmacy Services from $47.00 to $51.00 and gave the stock a “buy” rating in a research report on Monday, September 21st. Oppenheimer boosted their target price on Guardian Pharmacy Services from $43.00 to $49.00 and gave the company an “outperform” rating in a research note on Friday, August 7th. Weiss Ratings upgraded Guardian Pharmacy Services from a “buy (b-)” rating to a “buy (b)” rating in a report on Monday, November 9th. Finally, KeyCorp started coverage on Guardian Pharmacy Services in a report on Tuesday, September 22nd. They set an “overweight” rating and a $52.00 target price for the company. Nine investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, Guardian Pharmacy Services has a consensus rating of “Moderate Buy” and a consensus target price of $45.57.

View Our Latest Report on GRDN

Guardian Pharmacy Services Price Performance

NYSE GRDN opened at $49.56 on Friday. The stock has a market capitalization of $3.14 billion, a PE ratio of 42.36, a PEG ratio of 2.59 and a beta of 0.06. Guardian Pharmacy Services has a 1 year low of $26.34 and a 1 year high of $50.58. The business’s 50-day moving average is $42.48 and its 200 day moving average is $38.78.

Guardian Pharmacy Services (NYSE:GRDN – Get Free Report) last announced its quarterly earnings results on Thursday, November 5th. The company reported $0.33 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.31 by $0.02. The company had revenue of $371.07 million for the quarter, compared to the consensus estimate of $365.76 million. Guardian Pharmacy Services had a return on equity of 30.29% and a net margin of 5.13%. As a group, equities research analysts anticipate that Guardian Pharmacy Services will post 1.18 earnings per share for the current year.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. First Trust Advisors LP raised its holdings in Guardian Pharmacy Services by 30.3% in the third quarter. First Trust Advisors LP now owns 601,238 shares of the company’s stock worth $24,518,000 after purchasing an additional 139,931 shares in the last quarter. Voya Investment Management LLC bought a new position in shares of Guardian Pharmacy Services in the 3rd quarter worth about $238,000. Teachers Retirement System of The State of Kentucky increased its stake in shares of Guardian Pharmacy Services by 54.7% in the 3rd quarter. Teachers Retirement System of The State of Kentucky now owns 38,372 shares of the company’s stock worth $1,565,000 after acquiring an additional 13,572 shares in the last quarter. Bessemer Group Inc. increased its stake in shares of Guardian Pharmacy Services by 3.2% in the 3rd quarter. Bessemer Group Inc. now owns 565,598 shares of the company’s stock worth $23,064,000 after acquiring an additional 17,569 shares in the last quarter. Finally, Riverbridge Partners LLC lifted its position in Guardian Pharmacy Services by 4.1% during the 3rd quarter. Riverbridge Partners LLC now owns 254,630 shares of the company’s stock valued at $10,384,000 after acquiring an additional 10,045 shares during the period.

Guardian Pharmacy Services Company Profile

(Get Free Report)

Guardian Pharmacy Services, Inc. provides pharmacy services to people living in long-term care and residential care settings. Its customers include assisted living and skilled nursing communities, behavioral health facilities, and other group-living providers. The company supplies prescription medications and offers medication packaging, delivery, consulting, and clinical support. Its services are designed to help care providers manage residents’ medication needs and support continuity of care. Founded in 2004, Guardian operates a network of pharmacies serving communities across the United States.

Further Reading

Analyst Recommendations for Guardian Pharmacy Services (NYSE:GRDN)

Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.